CV benefit claim for AstraZeneca's dapagliflozin OK'd in China

SeekingAlpha

28 Oct 2020 0 shares 1 views

CV benefit claim for AstraZeneca's dapagliflozin OK'd in China

CV benefit claim for AstraZeneca's dapagliflozin OK'd in China

SeekingAlpha

Published 28 Oct 2020

You might like